MENU
KMDA
AS OF
Feb 4, 04:28 PM (EDT)
Price
$8.10
Change
-$0.09 (-1.10%)
Capitalization
474M
42 days until earnings call
Intraday BUY SELL Signals
+Compare
KMDA
Stock ticker: NASDAQ
AS OF
Feb 4, 04:28 PM (EDT)
Price
$8.10
Change
-$0.09 (-1.10%)
Capitalization
474M

KMDA Kamada Ltd Forecast, Technical & Fundamental Analysis

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company... Show more

Industry: #Biotechnology
KMDA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for KMDA with price predictions
Feb 03, 2026

KMDA sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for KMDA moved above the 200-day moving average on January 08, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 26, 2026. You may want to consider a long position or call options on KMDA as a result. In of 102 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where KMDA advanced for three days, in of 243 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 141 cases where KMDA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for KMDA moved out of overbought territory on January 28, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 51 cases where KMDA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for KMDA turned negative on February 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KMDA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

KMDA broke above its upper Bollinger Band on January 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KMDA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KMDA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.779) is normal, around the industry mean (29.792). P/E Ratio (23.371) is within average values for comparable stocks, (74.095). Projected Growth (PEG Ratio) (0.649) is also within normal values, averaging (2.035). KMDA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.029). P/S Ratio (2.736) is also within normal values, averaging (116.680).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
KMDA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

KMDA is expected to report earnings to fall 65.52% to 10 cents per share on March 18

Kamada Ltd KMDA Stock Earnings Reports
Q4'25
Est.
$0.10
Q3'25
Beat
by $0.20
Q2'25
Beat
by $0.11
Q1'25
Est.
$0.07
Q4'24
Beat
by $0.02
The last earnings report on November 10 showed earnings per share of 28 cents, beating the estimate of 9 cents. With 13.84K shares outstanding, the current market capitalization sits at 474.00M.
A.I. Advisor
published General Information

General Information

a company, which engages in pharmaceutical business

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2 Holzman Street
Phone
+972 89406472
Employees
378
Web
https://www.kamada.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LCMNX9.510.04
+0.42%
Miller Income C
CFWCX28.370.03
+0.11%
Calvert Global Water C
FGRSX46.69N/A
N/A
Federated Hermes Intl Leaders R6
JEPSX14.52-0.03
-0.21%
JPMorgan Equity Premium Income R5
VIKSX9.94-0.23
-2.26%
Virtus KAR Small-Mid Cap Growth I

KMDA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KMDA has been loosely correlated with LFCR. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if KMDA jumps, then LFCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMDA
1D Price
Change %
KMDA100%
-0.61%
LFCR - KMDA
35%
Loosely correlated
-6.46%
TEVA - KMDA
31%
Poorly correlated
+2.06%
SGIOY - KMDA
27%
Poorly correlated
+2.07%
OGI - KMDA
27%
Poorly correlated
+3.97%
CRDL - KMDA
25%
Poorly correlated
+6.17%
More

Groups containing KMDA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMDA
1D Price
Change %
KMDA100%
-0.61%
Pharmaceuticals: Generic
industry (214 stocks)
16%
Poorly correlated
-0.59%